Dual Binding Site and Selective Acetylcholinesterase Inhibitors Derived from Integrated Pharmacophore Models and Sequential Virtual Screening

<table>The difference in costs between HYPOGEN runs and the scrambled runs for Hypo1_A. The 95% confidence level was selected.</table>

BioMed Research International

fig6

Figure 6

Figure 6: Dual Binding Site and Selective Acetylcholinesterase Inhibitors Derived from Integrated Pharmacophore Models and Sequential Virtual Screening 

Figure 6 | Dual Binding Site and Selective Acetylcholinesterase Inhibitors Derived from Integrated Pharmacophore Models and Sequential Virtual Screening 